# Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR

> **NCT06015997** · — · UNKNOWN · sponsor: **Jordan Collaborating Cardiology Group** · enrollment: 100 (estimated)

## Conditions studied

- ATTR Amyloidosis Wild Type
- Severe Aortic Stenosis
- Aortic Valve Stenosis
- Middle East Studies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06015997
- **Lead sponsor:** Jordan Collaborating Cardiology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-11-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015997, "Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06015997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*